Concurrent chemoradiotherapy for patients with locally advanced head & neck squamous cell carcinoma (LA-HNSCC)
Background: Concurrent chemoradiation improves survival over radiation alone in unresectable HNSCC. We evaluated the efficacy and toxicity of concurrent FP-RT in patients with unresectable LA-HNSCC. Patients & Method: FP-RT: 5-FU 200mg/m2 (Day 1-6, 8-13, 35 -40, 42-47: CI), CDDP 40mg/m2 (Day 1,...
Saved in:
| Published in | OTOLOGIA FUKUOKA Vol. 46; no. 4Supplement2; pp. S68 - S70 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Japanese |
| Published |
JIBI TO RINSHO KAI
20.09.2000
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0447-7227 2185-1034 |
| DOI | 10.11334/jibi1954.46.4Supplement2_S68 |
Cover
| Abstract | Background: Concurrent chemoradiation improves survival over radiation alone in unresectable HNSCC. We evaluated the efficacy and toxicity of concurrent FP-RT in patients with unresectable LA-HNSCC. Patients & Method: FP-RT: 5-FU 200mg/m2 (Day 1-6, 8-13, 35 -40, 42-47: CI), CDDP 40mg/m2 (Day 1, 8, 35, 42), RT 2 Gy/day (Day 1-5, 8-12, 15-19, 35 -39, 42-46, 49-53). After radiation therapy to 60 Gy, patients were evaluated for response and those with CR at the primary site continued radiotherapy up to 66-72 Gy. Patients who achieved CR in primary site and had residual but resectable neck lymph nodes underwent neck dissection after completion of radiotherapy. Results: Patient characteristics were: F/M: 3/24, Age (median, range: 57, 41-67), Stage III/IV: 1/26. Hematological toxicities include: 7% grade 4 leukopenia and neutropenia, 44% grade 3 anemia and 4% grade 4 thrombocytopenia. Grade 3 mucositis was seen in 70%. Two patients died with methicillin resistance Staphylococcus aureus pneumonia. After FP-RT, overall response rate was 85% including 22% CR. CR rate of primary site and that of lymph nodes were 60% and 30%, respectively. 3/4 patients who underwent radical neck resection had residual tumor. Laryngeal preservation rate at 1 year was 44% in patients who were followed more than 1 year. Finally overall CR rate was 33%. Median survival time was 11 months. Conclusion: Although supportive cares were very difficult, FP-RT was the feasible and tolerable treatment. After FP-RT, there were no major complication for neck dissection, but it was very difficult to perform the modified neck dissection. FP-RT was one of the effective regimen for laryngeal preservation in the treatment of LA-HNSCC. |
|---|---|
| AbstractList | Background: Concurrent chemoradiation improves survival over radiation alone in unresectable HNSCC. We evaluated the efficacy and toxicity of concurrent FP-RT in patients with unresectable LA-HNSCC. Patients & Method: FP-RT: 5-FU 200mg/m2 (Day 1-6, 8-13, 35 -40, 42-47: CI), CDDP 40mg/m2 (Day 1, 8, 35, 42), RT 2 Gy/day (Day 1-5, 8-12, 15-19, 35 -39, 42-46, 49-53). After radiation therapy to 60 Gy, patients were evaluated for response and those with CR at the primary site continued radiotherapy up to 66-72 Gy. Patients who achieved CR in primary site and had residual but resectable neck lymph nodes underwent neck dissection after completion of radiotherapy. Results: Patient characteristics were: F/M: 3/24, Age (median, range: 57, 41-67), Stage III/IV: 1/26. Hematological toxicities include: 7% grade 4 leukopenia and neutropenia, 44% grade 3 anemia and 4% grade 4 thrombocytopenia. Grade 3 mucositis was seen in 70%. Two patients died with methicillin resistance Staphylococcus aureus pneumonia. After FP-RT, overall response rate was 85% including 22% CR. CR rate of primary site and that of lymph nodes were 60% and 30%, respectively. 3/4 patients who underwent radical neck resection had residual tumor. Laryngeal preservation rate at 1 year was 44% in patients who were followed more than 1 year. Finally overall CR rate was 33%. Median survival time was 11 months. Conclusion: Although supportive cares were very difficult, FP-RT was the feasible and tolerable treatment. After FP-RT, there were no major complication for neck dissection, but it was very difficult to perform the modified neck dissection. FP-RT was one of the effective regimen for laryngeal preservation in the treatment of LA-HNSCC.
局所進行頭頸部扁平上皮癌を対象にCDDP/5-FU併用放射線療法を行い、その安全性・有効性について検討した。病状による呼吸・栄養・瘍痛管理が当初から必要で、補助療法が困難を極める症例が多くを占めた。急性毒性としてはgrade4の好中球減少が7%、grade3の口内炎、咽頭炎が70%に認められた。晩期反応としては唾液減少による口渇が認められた。奏功率85%、CR率22%であり、MSTは11カ月であった。治療開始から1年以上経過した18例中8人が生存中で全例喉頭機能が温存されている。管理は難しいもののこの治療法は耐用性があり、局所進行頭頸部癌に対しては生存率・喉頭機能温存においても有用な方法であると考えられた。 Background: Concurrent chemoradiation improves survival over radiation alone in unresectable HNSCC. We evaluated the efficacy and toxicity of concurrent FP-RT in patients with unresectable LA-HNSCC. Patients & Method: FP-RT: 5-FU 200mg/m2 (Day 1-6, 8-13, 35 -40, 42-47: CI), CDDP 40mg/m2 (Day 1, 8, 35, 42), RT 2 Gy/day (Day 1-5, 8-12, 15-19, 35 -39, 42-46, 49-53). After radiation therapy to 60 Gy, patients were evaluated for response and those with CR at the primary site continued radiotherapy up to 66-72 Gy. Patients who achieved CR in primary site and had residual but resectable neck lymph nodes underwent neck dissection after completion of radiotherapy. Results: Patient characteristics were: F/M: 3/24, Age (median, range: 57, 41-67), Stage III/IV: 1/26. Hematological toxicities include: 7% grade 4 leukopenia and neutropenia, 44% grade 3 anemia and 4% grade 4 thrombocytopenia. Grade 3 mucositis was seen in 70%. Two patients died with methicillin resistance Staphylococcus aureus pneumonia. After FP-RT, overall response rate was 85% including 22% CR. CR rate of primary site and that of lymph nodes were 60% and 30%, respectively. 3/4 patients who underwent radical neck resection had residual tumor. Laryngeal preservation rate at 1 year was 44% in patients who were followed more than 1 year. Finally overall CR rate was 33%. Median survival time was 11 months. Conclusion: Although supportive cares were very difficult, FP-RT was the feasible and tolerable treatment. After FP-RT, there were no major complication for neck dissection, but it was very difficult to perform the modified neck dissection. FP-RT was one of the effective regimen for laryngeal preservation in the treatment of LA-HNSCC. |
| Author | FUJII, Hirofumi |
| Author_FL | 藤井 博文 |
| Author_FL_xml | – sequence: 1 fullname: 藤井 博文 |
| Author_xml | – sequence: 1 fullname: FUJII, Hirofumi organization: Division of Oncology/Hematology, National Cancer Center Hospital |
| BackLink | https://cir.nii.ac.jp/crid/1390001205499339392$$DView record in CiNii |
| BookMark | eNpVkE1LxEAMhgdRcP34D3NQ0UPX-Wq3c5SirrDqYb2XNE3trO20TrvK_nsLfoCXhPA-CeE5Yvu-88TYuRRzKbU21xtXOGljMzfJ3Ky3fd9QS35U-TpJ99hMyTSOpNBmn82EMYtoodTikJ0OgyuEUEIYleoZ81nncRvCtMmxprYLULpurClAv-NVF3gPo5vSgX-6seZNh9A0Ow7lB3ikktcEJb_gnvCND-9baLvtwJGahiMEdL5rgV-ubqLl0zrLrk7YQQXNQKc__Zi93N2-ZMto9Xz_kN2soo21KtIaEqtkYtKUpMEyAbSEUBSikmCtUVosUGisEOMykbZChbpKgKSSEFOhj9nZ91nvXD49MVWprRBCKhEba7W22qoJe_zGNsMIr5T3wbUQdjmE0WFD-a_i3CT5P8XTPFn-47CGkJPXX29bfjk |
| ContentType | Journal Article |
| Copyright | JIBI TO RINSHO KAI |
| Copyright_xml | – notice: JIBI TO RINSHO KAI |
| DBID | RYH |
| DOI | 10.11334/jibi1954.46.4Supplement2_S68 |
| DatabaseName | CiNii Complete |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | 局所進行頭頸部扁平上皮癌に対する化学療法併用放射線療法 |
| DocumentTitle_FL | 局所進行頭頸部扁平上皮癌に対する化学療法併用放射線療法 |
| EISSN | 2185-1034 |
| EndPage | S70 |
| ExternalDocumentID | 130004133494 article_jibi1954_46_4Supplement2_46_S68_article_char_en |
| GroupedDBID | ABJNI ACGFS ALMA_UNASSIGNED_HOLDINGS JSF KQ8 RJT RYH |
| ID | FETCH-LOGICAL-j992-33a69216488e14cd6ac9ecabb0f1a9942307c03cfcc5d619fc2c3f6ae121a5eb3 |
| ISSN | 0447-7227 |
| IngestDate | Thu Jun 26 22:54:12 EDT 2025 Wed Sep 03 06:30:45 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Issue | 4Supplement2 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j992-33a69216488e14cd6ac9ecabb0f1a9942307c03cfcc5d619fc2c3f6ae121a5eb3 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jibi1954/46/4Supplement2/46_S68/_article/-char/en |
| ParticipantIDs | nii_cinii_1390001205499339392 jstage_primary_article_jibi1954_46_4Supplement2_46_S68_article_char_en |
| PublicationCentury | 2000 |
| PublicationDate | 2000/09/20 |
| PublicationDateYYYYMMDD | 2000-09-20 |
| PublicationDate_xml | – month: 09 year: 2000 text: 2000/09/20 day: 20 |
| PublicationDecade | 2000 |
| PublicationTitle | OTOLOGIA FUKUOKA |
| PublicationTitleAlternate | jibi to rinsho |
| PublicationTitle_FL | 耳鼻と臨床 耳鼻 OTOLOGIA FUKUOKA |
| PublicationYear | 2000 |
| Publisher | JIBI TO RINSHO KAI |
| Publisher_xml | – name: JIBI TO RINSHO KAI |
| SSID | ssib002004283 ssj0000400194 ssib005879669 ssib058493091 |
| Score | 1.3576077 |
| Snippet | Background: Concurrent chemoradiation improves survival over radiation alone in unresectable HNSCC. We evaluated the efficacy and toxicity of concurrent FP-RT... |
| SourceID | nii jstage |
| SourceType | Publisher |
| StartPage | S68 |
| SubjectTerms | シスプラチン フルオロウラシル 化学療法併用放射線療法 局所進行頭頸部癌 |
| Title | Concurrent chemoradiotherapy for patients with locally advanced head & neck squamous cell carcinoma (LA-HNSCC) |
| URI | https://www.jstage.jst.go.jp/article/jibi1954/46/4Supplement2/46_S68/_article/-char/en https://cir.nii.ac.jp/crid/1390001205499339392 |
| Volume | 46 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | jibi to rinsho, 2000/09/20, Vol.46(4Supplement2), pp.S68-S70 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2185-1034 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000400194 issn: 0447-7227 databaseCode: KQ8 dateStart: 19540101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELa6ISFeJhAgBgz5ARAoSnFi59fjqJiaTXSCdtLeIsdxtBSajq19gH-Cf5k7x0lTDSGYeLFaq3Zq39fz3dX3HSEvtQ5VngTc5eBruCJRhRvnTLhBHkc-F0rKABOFP07C8Zk4Pg_OB4OfvVtL61U-VD9-m1dyG6lCH8gVs2T_QbLdpNABr0G-0IKEof0rGY-WtbL8SrD3C5BmUdmMquYepmVNtSls5tz6-n3zvz8o4sLIvtbqi3P9bS0xEOBgMB8pq1VVLxfSFP04dMeT6WjUxg2sNTuv8gqN16uqvr5YdlA4O05Tc6RVoOTXi2orssDwGoTPNlo_fZ86s1PnczqZjk-dE8tO3egmISI38pu0_qE2fWAsIKmpjU1a5Wrjiw2IhKlUasKefk9pTpvCOvb8nTaFRG6qds4F6nZYGbLUDUU47M-XdbNssWdb2WTtsEyE2dYweA8js_ZzmOsG0Nohd3w4JrAWyMmnnj9mXMyeQosjcBc7exCMuYQzSz5kTAGBJrShMGs37C551a7m3Z_WAhbRHPwDJH7YqauqZ_TM7pM9663Qw-ZrPyCDuXxI6g3s6A3YUYAdbWFHEXbUwo62sKMIO_qaIuhoCzqKoKMd6OibFnJvH5HZ0YfZaOzash3uHK8ycy7DxAcvPI61J1QRSpVoJfOclZ5MEoGZB4pxVSoVFOC-l8pXvAyl9nwPFEPOH5PdelnrJ4TqPAqk9FlYRAHy6CVMMV9LLqQKy1h6--So2aPssqFmyW4p7n1yAHucwQqhBZ_IxGcZhk44T8CDePq_HvSM3Nv80p6T3dXVWh-AVbvKXxik_QLGMKMW |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Concurrent+chemoradiotherapy+for+patients+with+locally+advanced+head+%26+neck+squamous+cell+carcinoma+%28LA-HNSCC%29&rft.jtitle=jibi+to+rinsho&rft.au=FUJII%2C+Hirofumi&rft.date=2000-09-20&rft.pub=JIBI+TO+RINSHO+KAI&rft.issn=0447-7227&rft.eissn=2185-1034&rft.volume=46&rft.issue=4Supplement2&rft.spage=S68&rft.epage=S70&rft_id=info:doi/10.11334%2Fjibi1954.46.4Supplement2_S68&rft.externalDocID=article_jibi1954_46_4Supplement2_46_S68_article_char_en |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0447-7227&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0447-7227&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0447-7227&client=summon |